한국어
Quantus

Nuon

123840 · KOSDAQ
₩1,655-2.30%
2026-09-04 close

Nuon last closed at ₩1,655 (-2.30%) on 2026-09-04. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

B
Overall: IT하드웨어 106/211 · top 50%
Factor composite · relative position in sector

PER — · PBR 0.06 — own-history percentile 0/100 · 100/100

Open self-history band
PER0/100
PBR100/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -1.82
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-1.82
Beneish M-Score
-1.70

Statistical manipulation-risk signal

Sloan accrual
-24.77%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

7/9Strong

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score7/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioPass
  • No new sharesPass

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Revenue qualityDanger

매출 흑자인데 영업CF 적자 (OCF/매출 -29%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

IT하드웨어

This stock is in IT하드웨어: revenue rank 187 of 211, share 0%.

187 / 2110%revenue share

Who dominates this industry?

  1. 1LG이노텍24.4%
  2. 2삼성전기11.8%
  3. 3삼지전자3.9%
  4. 4에스에이엠티3.3%
  5. 5영풍3.2%
  6. 6뉴온0%

Concentration

DistributedCR3 40.1%
HHI 813211 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

MixedDivergent lenses

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
6.82
Direction
축소
Level
좁음
Years
7

Value lens

P90/P10
10.9
Median P/B
0.97
Level
넓음
n
193

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-171.5%
Interest coverage
-13.6x
Return on equity (ROE)
-37.9%

Operating margin −5pp

Operating loss
Interest coverageBase -13.6x adverse case -14x
Return on equity (ROE)Base -37.9% adverse case -33.2%

Revenue −15%

Interest coverage risk
Interest coverageBase -13.6x adverse case -11.6x
Return on equity (ROE)Base -37.9% adverse case -27.8%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -13.6x adverse case -10.5x
Return on equity (ROE)Base -37.9% adverse case -33%

Interest coverage limit

Already below the limit by 184.1pp

Interest coverage limit at an operating margin of 12.6%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-20

Suppliers disclosed by the company in its 2026-03-20 annual report.

Suppliers without disclosed amount

현삼추출물서흥Price comovement r=0.01 (1 year)콜마비앤에이치Price comovement r=-0.08 (1 year)코스맥스바이오알피바이오Price comovement r=0.06 (1 year)서흥헬스케어비오팜엠에스바이오텍에이치엘사이언스Price comovement r=0.07 (1 year)코스맥스엔비티Price comovement r=0.03 (1 year)대평피엘코스메틱+14 more

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 케이피엠테크91.06%2026-08-07 · 증감 0.00%p
  • 김택만16.52%2025-07-08 · 증감 +4.34%p

Connections

AI-extracted related companies · for reference

🔗 See in the full market map →

Recent filings

Nuon's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About Nuon
What technical signals does Nuon (123840) have?
Nuon current technical signals: no active technical signal.
Is Nuon a cup-and-handle pattern?
No. Nuon has no valid cup-and-handle signal right now.
What are Nuon's financials and valuation?
Nuon's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy